Rat Pulmonary Artery Smooth Muscle Cells
Cat.No.: CSC-C4138X
Species: Rat
Source: Lung; Artery
Cell Type: Smooth Muscle Cell
- Specification
- Background
- Scientific Data
- Q & A
- Customer Review
Cells are negative for bacteria, yeast, fungi, and mycoplasma and are characterized by immunofluorescent staining with antibodies to α-smooth muscle actin.
Cells can be expanded on a multiwell culture plate ready for experiments under the cell culture conditions specified by Creative Bioarray.
Repeated freezing and thawing of cells is not recommended.
Standard biochemical procedures performed with smooth muscle cell cultures include the assays of cell to cell interaction, PCR, Western blotting, immunoprecipitation, immunofluorescent staining, immunofluorescent flow cytometry or generating cell derivatives for desired research applications.
Rat Pulmonary Artery Smooth Muscle Cells (RPASMCs) are one of many cell types that comprise the pulmonary arterial system. As cells found in the medial layer of the pulmonary artery, RPASMCs maintain vascular tone and provide structural support. Pulmonary smooth muscle cells are highly plastic and transition between a "contractile phenotype" (regulating blood pressure) and "synthetic phenotype" (repairing/remodeling tissue). When cultured, they display a "hill-and-valley" pattern of proliferation and express cell surface markers such as α-smooth muscle actin (α-SMA) and smooth muscle myosin heavy chain (SM-MHC).
RPASMCs are often used to model Pulmonary Arterial Hypertension (PAH). Pulmonary artery smooth muscle cells are usually cited in papers examining possible molecular causes of PAH including cues that trigger vascular remodeling events such as hyper-proliferation and apoptosis-resistance during hypoxic exposures. Papers targeting HIF-signaling and dysregulation of Kv channels within PASMCs cause pulmonary vasoconstriction.
RPASMCs can also be used to study mechanotransduction from stretching and for high-throughput drug screening. Primary RPASMCs are the preferred in vitro assay to study calcium signaling and vasodilatory drugs because their responses best emulate the response of an intact rat lung before in vivo animal models are utilized.

Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1
Background
This study investigates the role of cold-inducible RNA-binding protein (CIRP) in monocrotaline-induced pulmonary artery hypertension (PAH). CIRP was downregulated in pulmonary artery endothelium after monocrotaline treatment, and Cirp-knockout rats developed more severe PAH with exacerbated endothelial damage. Proteomics and RNA immunoprecipitation identified Caveolin1 (CAV1) and CAVIN1 as downstream targets of CIRP. Loss of CIRP reduced CAV1/CAVIN1 expression and increased endothelial apoptosis and permeability, while CAV1 or CAVIN1 overexpression counteracted these effects. CIRP also modulated endothelial-mediated smooth muscle proliferation, suggesting CIRP protects against PAH by regulating CAV1/CAVIN1.
Key Findings
CIRP was downregulated predominantly in pulmonary artery endothelium after monocrotaline (MCT) injection. Cirp-knockout rats exhibited exacerbated PAH, with higher right ventricular systolic pressure, greater right ventricular hypertrophy, and worsened pulmonary artery acceleration/ejection time after MCT. Proteomics and RNA immunoprecipitation identified Caveolin1 (Cav1) and Cavin1 as direct CIRP targets; CIRP bound their mRNAs, and this binding decreased after monocrotaline pyrrole (MCTP) treatment. CAV1 and CAVIN1 expression was lower in MCT-treated Cirp-KO lungs, especially in endothelium. In rPAECs, CIRP deficiency intensified MCTP-induced apoptosis, permeability, and LDH release, which were counteracted by Cav1 or Cavin1 overexpression. Conversely, Cav1/Cavin1 knockdown abolished CIRP overexpression-mediated protection. Conditioned medium from MCTP-treated CIRP-deficient rPAECs promoted rPASMC proliferation, partially explaining intimal media thickening. Thus, CIRP protects against MCT-induced PAH by regulating CAV1 and CAVIN1.
Contribution
Creative Bioarray provided rat pulmonary artery endothelial cells (rPAECs) and rat pulmonary artery smooth muscle cells (rPASMCs) used for in vitro experiments. These cells enabled mechanistic studies of CIRP, CAV1/CAVIN1, MCTP-induced endothelial injury, apoptosis, permeability, and smooth muscle proliferation.
NCAM1 Contributes to the Proliferation and Migration of PDGF-BB-Induced PASMCs
Pulmonary hypertension (PH) involves pulmonary arterial remodeling. Neural cell adhesion molecule 1 (NCAM1) is a cell surface glycoprotein that participates in diverse diseases such as cardiovascular disease, but its role in PH remains unclear. Herein, Chen's team examined the role of NCAM1 in PDGF-BB-stimulated rat pulmonary artery smooth muscle cells (PASMCs). NCAM1 expression was significantly increased in PDGF-BB-stimulated PASMCs at the mRNA level (Fig. 1A) and protein level (Fig. 1B). To determine the roles of NCAM1, they knocked down NCAM1 expression with siRNA (Fig. 2A). NCAM1 knockdown partially inhibited PDGF-BB-induced PCNA increase (Fig. 2B) and suppressed PDGF-BB-induced cell proliferation (Fig. 2C and D) as assessed by CCK-8 assay and EdU incorporation assay. Moreover, NCAM1 knockdown inhibited PDGF-BB-induced PASMC migration (Fig. 2E, F).


Ask a Question
Write your own review